Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Innocan Pharma Corp C.INNO

Alternate Symbol(s):  INNPF

Innocan Pharma Corporation is an Israel-based company active in the pharmaceuticals and wellness sectors. In the pharmaceuticals sector, the Company aims to provide a safe, non-opioid chronic pain management solutions for both animals and humans. To achieve this aim, the Company developed a CBD-loaded liposome drug delivery platform with exact dosing, prolonged and controlled release of... see more

Recent & Breaking News (CSE:INNO)

Innocan Pharma and Polyflame Announce an Exclusive Distribution Agreement in France

Newsfile April 22, 2021

Richard Serbin, Former Johnson & Johnson's VP and a Leading Global Strategy Advisor in the Healthcare Industry, to Join Innocan Pharma's Scientific Advisory Committee

Newsfile April 6, 2021

Innocan Reports Q4 2020 Financial Results

Newsfile April 1, 2021

Dr. Mitchell Kline joins Innocan Pharma’s (CSE:INNO) Scientific Advisory Committee

John Ballem  March 23, 2021

Leading American Dermatologist Dr. Mitchell Kline to Join Innocan Pharma's Scientific Advisory Committee

Newsfile March 23, 2021

Innocan Pharma Announces Proceeds of CDN $ 3.1M from the Exercise of Warrants Since January 1, 2021

Newsfile March 16, 2021

Innocan Pharma’s (CSE:INNO) patent application is pending for cannabis-based anti-itch treatment

Brieanna McCutcheon  March 10, 2021

Innocan Pharma Announces Patent Application for Novel Cannabis-Based Anti-Itch Treatment

Newsfile March 10, 2021

Innocan Pharma Announces the Completion of its First Full-Scale Manufacturing Run in the US and the Launching of its US Commercial Online Platform

Newsfile February 22, 2021

The StockTalk Cannabis Report: Jan 29, 2021

Dave Jackson January 29, 2021

Innocan Pharma Announces Proceeds of CDN $ 1.8M from the Exercise of Warrants Since December 1, 2020

Newsfile January 28, 2021

Innocan Pharma Produces CBD Loaded Liposomes

Brieanna McCutcheon  January 25, 2021

Innocan Pharma (CSE:INNO) produces CBD loaded liposomes

Brieanna McCutcheon  January 22, 2021

Innocan Pharma Announces Successful Production of CBD Loaded Liposomes under Aseptic Conditions

Newsfile January 22, 2021

Innocan Pharma Successfully Completes Large Scale Production of Exosomes

Newsfile January 14, 2021

Innocan Pharma Announces the Launch of Its Commercial Website

Newsfile January 5, 2021

Innocan Pharma Announces Closing of Private Placement

Newsfile December 31, 2020

Innocan Pharma Announces the Successful Completion of Its First Full-Scale Manufacturing Run in Europe and the Commencement of Its Full-Scale Manufacturing Run in the USA

Newsfile December 16, 2020

Innocan Pharma Completes Its Trademark Registration in the EU, UK and Switzerland

Newsfile December 10, 2020

Innocan Pharma to Participate in the Lytham Partners End of Year 1x1 Conference

Newsfile December 3, 2020